With a growing interest in the association between the CCND1 polymorphisms and RCC risk, several studies have tested the hypothesis that the CCND1 polymorphisms were associated with RCC risk [33–35], but the findings remained inconsistent. This evidence concerns the gene CCND1 and renal cell adenocarcinoma.